From the first days a molecular entity shows promise, through all phases of investigation, development and – fingers crossed – commercialization, the science and market experts at BioScience Communications help companies map sound communications plans onto their broader strategic objectives.

We’ve tailored communications plans to address clinicians’ current knowledge, viewpoints and practices regarding disease states, pathways and therapeutic options across areas from autoinflammatory diseases to oncology. The keys to our success are expertise and longevity – partnerships between our senior members and client medical affairs and commercial teams have in several cases lasted longer than a decade. Throughout, we provide a solid resource of scientific, clinical and industry insights to ensure that communication tactics remain grounded in strategy.